In UK Osborne Clarke, advised on the matter. Osborne Clarke advised Basecamp Research Ltd with a team including Matthew Edwards (Picture – Corporate M&A). Basecamp Research...
Basecamp Research Ltd’s $20 Million Series A Funding Round
Turbine’s €20 Million Financing Round
In UK Osborne Clarke, advised on the matter. Osborne Clarke advised Turbine with a team including Matthew Edwards (Picture – Corporate M&A). Turbine, a company developing...
Epitopea’s US$14 Million Financing to Advance Cancer Immunotherapeutics
In UK Osborne Clarke, advised on the matter. Osborne Clarke advised Advent Life Sciences, Cambridge Innovation Capital, CTI Life Sciences Fund, Fonds de solidarité FTQ with...
Redx Pharma plc’s £34.3 Million Placing
In UK Osborne Clarke, advised on the matter. Osborne Clarke advised Panmure Gordon, Stifel Nicolaus Europe Limited, WG Partners with a team including Matthew Edwards (Picture...
Uniphar plc’s Acquisition of Events4Healthcare
In UK Osborne Clarke, advised on the matter. Osborne Clarke advised Uniphar Group with a team including Matthew Edwards (Picture – Corporate M&A), Mathew Oliver (Tax...
Uniphar plc’s Acquisition of Devonshire Healthcare Services
In UK Osborne Clarke, advised on the matter. Osborne Clarke advised Uniphar Group with a team including Matthew Edwards (Picture – Corporate M&A), Mathew Oliver (Tax...
Forefront RF’s £1.5 Million Investment Round
In UK Osborne Clarke, advised on the matter. Osborne Clarke advised Business Growth Fund, Foresight Williams Technology, Science Create Ventures with a team including Matthew Edwards...
Science Creates Ventures’ First Investment In CytoSeek
In UK Osborne Clarke, advised on the matter. Osborne Clarke advised Science Creates Ventures with a team including Matthew Edwards (Picture – Corporate M&A), Erika Jupe...